Abstract
In the treatment of acute maxillary sinusitis, azithromycin offers an advantage over phenoxymethylpenicillin in that a complete course of treatment requires drug administration once daily for only three days. In this double-blind, parallel-group, multicenter study, 438 patients with radiographically verified maxillary sinusitis were randomly assigned to receive either 500 mg azithromycin once daily for three days (221 patients) or 1.3 g phenoxymethylpenicillin three times daily for ten days (217 patients). Nasal secretion, maxillary tenderness and pain, nasal obstruction, general malaise, and hyposmia, were assessed at the start of the study and on days 4, 11, and 25 of treatment. After 11 days 58% of the patients in the azithromycin group were cured versus 51% in the penicillin group; after 25 days the cure rate was 79% versus 76%, respectively. When both cure and improvement were considered, the corresponding figures after 11 days were 97% (azithromycin) and 95% (penicillin); after 25 days they were 92% and 88%, respectively. Adverse events, predominantly gastrointestinal, occurred in 73 (33%) of the azithromycin-treated patients and in 87 (40.1%) of those treated with penicillin. No difference in efficacy was found between the two drugs in the treatment of acute maxillary sinusitis, and the adverse effects were comparable. The short duration of treatment with azithromycin offers a significant advantage over treatment with phenoxymethylpenicillin.
References
Dingle JH, Badger GF, Jordan WS Jr: Illness in the home: study of 25,000 illnesses in a group of Cleveland families. Press of Western Reserve University, Cleveland, OH, 1964, p. 347.
van Duijn NR Brouwer HJ, Lamberts H: Use of symptoms and signs to diagnose maxillary sinusitis in general practice: comparison with ultrasonography. British Medical Journal 1992, 305: 684–687.
Bro F, Mabeck CE: Treatment of infectious diseases in general practice with antibiotics. Ugeskrift for Læger 1986, 148: 2540–2543.
Gwaltney J: Sinusitis. In: Mandell GL, Douglas RG, Bennet JS (ed): Principles and practice of infectious diseases. John Wiley & Sons, New York, 1990, p. 510–514.
Vennerød AM (ed): Norsk legemiddelhåndbok 1994–95. Norsk legemiddelhåndbok I/S, Oslo, 1994, p. 500.
Lindbæk M: Acute infections in nose and paranasal sinuses — diagnosis and treatment. In: Madsen S. Waerstad A, Westbye O, Beerman B, Strandberg K (ed): Norwegian Medicines Control Authority & Medical Products Agency. Workshop: treatment of acute infections of the respiratory tract in primary health care. Falch Hurtigtrykk, Oslo, 1995, p. 125–136.
Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R: Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrobial Agents and Chemotherapy 1987, 31: 1939–1947.
Barry AL: In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 867–869.
Peters DH, Friedel HA, McTavish D: Azithromycin. Drugs 1992, 44: 750–799.
Karma P, Pukander J, Penttila M: Azithromycin concentrations in sinus fluid and mucosa after oral administration. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 856–859.
Carenfelt C, Eneroth CM, Lundberg C, Wretlind B: Evaluation of the antibiotic effect of treatment of maxillary sinusitis. Scandinavian Journal of Infectious Diseases 1975, 7: 259–264.
Ekedahl C, Holm SE, Bergholm AM: Penetration of antibiotics into the normal and diseased maxillary sinus mucosa. Scandinavian Journal of Infectious Diseases 1978, 10, Supplement 14: 279–284.
Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS: General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clinical Infectious Diseases 1992, 15, Supplement 1: 62–88.
Wald ER: Sinusitis in children. New England Journal of Medicine 1992, 326: 319–323.
Hansen JG, Schmidt H, Rosborg J, Lund E: Predicting acute maxillary sinusitis in a general practice population. British Medical Journal 1995, 311: 233–236.
Gwaltney JM Jr, Sydnor A Jr, Sande MA: Etiology and antimicrobial treatment of acute sinusitis. Annals of Otology, Rhinology and Laryngology 1981, 90, Supplement: 68–71.
Winther B, Gwaltney JM Jr: Therapeutic approach to sinusitis: anti-infectious therapy as the baseline of management. Archives of Otolaryngology — Head and Neck Surgery 1990, 103: 876–878.
Axelsson A, Grebelius N, Chidekel N, Jensen C: The correlation between the radiological examination and the irrigation findings in maxillary sinusitis. Acta Otolaryngologica (Stockholm) 1970, 69: 302–306.
Berg O, Carenfelt C: Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngologica (Stockholm) 1988, 105: 343–349.
Axelsson A, Runze U: Comparison of subjective and radiological findings during the course of acute maxillary sinusitis. Annals of Otology, Rhinology and Laryngology 1983, 92: 75–77.
Havas T, Motley JA, Gullane J: Prevalence of incidental abnormalities on computed tomography scans of the paranasal sinuses. Archives of Otolaryngology — Head and Neck Surgery 1988, 114: 856–859.
Casiano RR: Azithromycin and amoxillin in the treatment of acute maxillary sinusitis. American Journal of Medicine 1991, 91, Supplement 3A: 27–30.
Felstead SJ, Daniel R and European Azithromycin Study Group: Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxicillin. Journal of International Medical Research 1991, 19: 363–372.
Scandinavian Study Group: Locarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Journal of Antimicrobial Chemotherapy 1993, 31: 949–961.
Gehanno P, Boucot I, Berche P, Ulrich J: Clinical efficacy and tolerability of cef ixime in the treatment of acute sinusitis. Drugs 1991, 42, Supplement 4: 19–24.
Helin I, Andreasson L, Jannert M, Pettersson H: Acute sinusitis in children — results of different therapeutic regimens. Helvetica Paediatrica Acta 1982, 37: 83–88.
Müller O: Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections. Journal of Antimicrobial Chemotherapy 1993, 31, Supplement E: 137–146.
Fyllingen G, Arnesen AR, Rønnevig J: Phenoxymethylpenicillin two or three times daily in bacterial upper respiratory tract infections: A blinded, randomized and controlled clinical study. Scandinavian Journal of Infectious Diseases 1991, 23: 755–761.
Husfeldt P, Egede F, Nielsen PB: Antibiotic treatment of sinusitis in general practice. A double blind study comparing ofloxacin and erythromycin. European Archives of Otolaryngology 1993, 250, Supplement 1: 23–25.
Amin NM, Breadon G: An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. Clinical Therapeutics 1995, 17: 701–707.
von Sydow C, Axelsson A, Jensen C: Treatment of acute maxillary sinusitis. Rhinology 1984, 22: 247–254.
Hopkins SJ: Clinical toleration and safety of azithromycin in adults and children. Reviews in Contemporary Pharmacotherapy 1994, 5: 383–389.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haye, R., Lingaas, E., Høivik, H.O. et al. Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis. Eur. J. Clin. Microbiol. Infect. Dis. 15, 849–853 (1996). https://doi.org/10.1007/BF01691214
Issue Date:
DOI: https://doi.org/10.1007/BF01691214